Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
Some energy companies, including a supermajor, have seen some insider buying.
Chief executive officers were among those stepping up to the buy window during the week.
Midway through trading Friday, the Dow traded up 0.07% to 35,525.67 while the NASDAQ rose 0.03% to 14,821.05. The S&P also rose, gaining 0.07% to 4,463.78.